DK564088A - Nukleosidderivater - Google Patents

Nukleosidderivater

Info

Publication number
DK564088A
DK564088A DK564088A DK564088A DK564088A DK 564088 A DK564088 A DK 564088A DK 564088 A DK564088 A DK 564088A DK 564088 A DK564088 A DK 564088A DK 564088 A DK564088 A DK 564088A
Authority
DK
Denmark
Prior art keywords
nucleoside
Prior art date
Application number
DK564088A
Other languages
English (en)
Other versions
DK564088D0 (da
Inventor
Steve Tam
John Joseph Partridge
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK564088D0 publication Critical patent/DK564088D0/da
Publication of DK564088A publication Critical patent/DK564088A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK564088A 1987-10-09 1988-10-07 Nukleosidderivater DK564088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10722187A 1987-10-09 1987-10-09

Publications (2)

Publication Number Publication Date
DK564088D0 DK564088D0 (da) 1988-10-07
DK564088A true DK564088A (da) 1989-04-10

Family

ID=22315505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK564088A DK564088A (da) 1987-10-09 1988-10-07 Nukleosidderivater

Country Status (14)

Country Link
EP (1) EP0311100A3 (da)
JP (1) JPH01132597A (da)
KR (1) KR890006624A (da)
AU (1) AU2355488A (da)
DK (1) DK564088A (da)
FI (1) FI884627A (da)
HU (1) HU201090B (da)
IL (1) IL87949A0 (da)
MC (1) MC1982A1 (da)
NO (1) NO884497L (da)
NZ (1) NZ226481A (da)
PT (1) PT88716B (da)
YU (1) YU187788A (da)
ZA (1) ZA886890B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
NZ223910A (en) * 1987-03-20 1991-02-26 Bristol Myers Co 2',3'-dideoxynucleosides, process for their production and intermediates therefor
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
JPH05501404A (ja) * 1989-11-06 1993-03-18 ニユコメド・アクシエセルカペト ヌクレオシド誘導体
US5192764A (en) * 1991-05-30 1993-03-09 Research Foundation Of State Of N.Y. Pyrazinone n-oxide nucleosides and analogs thereof
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
EP1042341A1 (en) * 1997-11-25 2000-10-11 Protarga Inc. Nucleoside analog compositions and uses thereof
US8552054B2 (en) 2001-03-23 2013-10-08 Luitpold Pharmaceuticals, Inc. Fatty amine drug conjugates
JP4634694B2 (ja) 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
KR100978904B1 (ko) 2001-12-14 2010-08-31 파마셋 인코포레이티드 바이러스 감염 치료용 n4-아실사이토신 뉴클레오사이드
US9326983B2 (en) 2013-08-01 2016-05-03 University Of Kentucky Research Foundation Compositions and methods for treating retinal degradation
EP3858826A1 (en) * 2015-02-26 2021-08-04 University of Kentucky Research Foundation Compositions and methods for treating retinal degradation
US11219623B2 (en) 2015-02-26 2022-01-11 University Of Kentucky Research Foundation Inflammasome inhibition for the treatment of Parkinson's disease, Alzheimer's disease and multiple sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5943550B2 (ja) * 1975-08-29 1984-10-23 田辺製薬株式会社 不飽和ヌクレオシドの製法
EP0206497B1 (en) * 1985-05-15 1994-07-20 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
WO1988007532A1 (en) * 1987-03-24 1988-10-06 Nycomed A.S. 2',3' dideoxyribofuranoxide derivatives
EP0294113A1 (en) * 1987-05-29 1988-12-07 The Wellcome Foundation Limited Therapeutic nucleosides
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds

Also Published As

Publication number Publication date
HU201090B (en) 1990-09-28
JPH01132597A (ja) 1989-05-25
AU2355488A (en) 1989-04-13
IL87949A0 (en) 1989-03-31
ZA886890B (en) 1989-05-30
NO884497L (no) 1989-04-10
DK564088D0 (da) 1988-10-07
NO884497D0 (no) 1988-10-07
YU187788A (en) 1990-04-30
FI884627A0 (fi) 1988-10-07
NZ226481A (en) 1992-01-29
HUT47592A (en) 1989-03-28
EP0311100A3 (de) 1990-10-31
KR890006624A (ko) 1989-06-14
FI884627A (fi) 1989-04-10
MC1982A1 (fr) 1989-11-23
EP0311100A2 (de) 1989-04-12
PT88716B (pt) 1992-12-31

Similar Documents

Publication Publication Date Title
DK713488A (da) Adenosinderivater
NO2001013I2 (no) Kapecitabin
DK112588A (da) Phenylcarbamat
DE3855333D1 (de) Therapeutische Nukleoside
ATA30988A (de) Alpinski
DK23489A (da) Nucleosidderivater
DK191688D0 (da) Terapeutiske nucleosider
ATA174488A (de) Alpinski
DK564088A (da) Nukleosidderivater
ATA224788A (de) Calcitoninsuppositorien
DK626989D0 (da) Adenosinderivater
DK140588D0 (da) Terapeutisk nucleosider
KR890700914A (ko) 멀티콘덴서 배열
AT389045B (de) Paraocclusaler loeffel
ATA48687A (de) Guellefass
ATA294988A (de) Haecksler
ATA282287A (de) Antivirale 8-phenylxanthine
FR2626574B1 (fr) Triphenylcerium
AT388649B (de) Sportschuh
DK725088A (da) Terapeutiske nucleosider
BR6702835U (pt) Prancha salva-vidas
BR6700856U (pt) Micro-semeador
BR6700226U (pt) Mosquetao
ATA257287A (de) Glykopeptidantibiotika
BR6701938U (pt) Multi-escada

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment